This content is only available for ASCRS Members
This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.
Filed Under
Astigmatism
Cataract
astigmatism correction
monofocal IOL
astigmatism-correcting IOL
toric IOL
2020 paper presentation
Purpose
To assess initial clinical outcomes in cataract patients with corneal astigmatism implanted with aberration-neutral, hydrophobic acrylic monofocal toric (MX60T, Bausch & Lomb, Inc.) intraocular lens (IOL) technology.
Methods
A single-center, single-surgeon, prospective case series involving 117 eyes of 86 patients (31 bilateral) with age-related cataract and clinically significant corneal astigmatism treated with standard cataract extraction and implanted with the MX60T IOL. Early postoperative outcomes were analyzed and compared with preoperative parameters. Clinical outcomes include: keratometry (K), uncorrected distance visual acuity (UCDVA), refractive cylinder (Cyl), manifest spherical equivalent (MRSE), and safety (reposition).
Results
Preoperative delta K, Cyl, and MRSE were 1.6±0.94D, -1.72D±1.0D, and -1.71±3.9D respectively. Average BCDVA without glare was 0.2±0.18 logMAR. At 1-week post-op, both cylinder and MRSE improved (Cyl: -0.34±0.54D and MRSE: plano±0.33D). Average UCDVA was 0.09±0.14 logMAR with 75% of eyes seeing 20/25 or better. One patient required repositioning and improved to 20/20 UCDVA with a 0.25D MRSE.
Conclusion
Patients implanted with aberration-neutral monofocal toric IOL demonstrated excellent uncorrected distance visual acuity and exceptional reduction in refractive cylinder postoperatively.
To assess initial clinical outcomes in cataract patients with corneal astigmatism implanted with aberration-neutral, hydrophobic acrylic monofocal toric (MX60T, Bausch & Lomb, Inc.) intraocular lens (IOL) technology.
Methods
A single-center, single-surgeon, prospective case series involving 117 eyes of 86 patients (31 bilateral) with age-related cataract and clinically significant corneal astigmatism treated with standard cataract extraction and implanted with the MX60T IOL. Early postoperative outcomes were analyzed and compared with preoperative parameters. Clinical outcomes include: keratometry (K), uncorrected distance visual acuity (UCDVA), refractive cylinder (Cyl), manifest spherical equivalent (MRSE), and safety (reposition).
Results
Preoperative delta K, Cyl, and MRSE were 1.6±0.94D, -1.72D±1.0D, and -1.71±3.9D respectively. Average BCDVA without glare was 0.2±0.18 logMAR. At 1-week post-op, both cylinder and MRSE improved (Cyl: -0.34±0.54D and MRSE: plano±0.33D). Average UCDVA was 0.09±0.14 logMAR with 75% of eyes seeing 20/25 or better. One patient required repositioning and improved to 20/20 UCDVA with a 0.25D MRSE.
Conclusion
Patients implanted with aberration-neutral monofocal toric IOL demonstrated excellent uncorrected distance visual acuity and exceptional reduction in refractive cylinder postoperatively.
View More Presentations from this Session
This presentation is from the session "SPS-102 Toric IOLs - Astigmatism" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.